Study title:
Schellong-G, Hoernig-I, Schwarze-E-W, Wannenmacher-M.
Kinderklinik, Muenster, FRG.
Risk factor adapted treatment of Hodgkin's lymphoma in childhood: strategies and results of three consecutive multicenter studies in the Federal Republic of Germany.
Recent results in cancer research. Fortschritte der Krebsforschung.
Progres dans les recherches sur le cancer, {Recent-Results-Cancer-Res}, 1989, vol. 117, p. 205-13, 7 refs, ISSN: 0080-0015.Schellong-G, Hoernig-I, Schwarze-E-W, Wannenmacher-M.
Kinderklinik, Muenster, FRG.
Risk factor adapted treatment of Hodgkin's lymphoma in childhood: strategies and results of three consecutive multicenter studies in the Federal Republic of Germany.
Recent results in cancer research. Fortschritte der Krebsforschung.
Progres dans les reche...
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|